Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

Endpoint:
short-term repeated dose toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
other:
Title:
Unnamed
Year:
1993
Report date:
1993

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: OECD 407 (1995)
GLP compliance:
yes
Limit test:
yes

Test material

Constituent 1
Reference substance name:
Dastib 845
IUPAC Name:
Dastib 845

Test animals

Species:
other: rat, Han:WIST

Administration / exposure

Route of administration:
oral: unspecified
Vehicle:
other: Maisol
Details on oral exposure:
Method of administration:
Magensonde
Duration of treatment / exposure:
Test duration: 28 days
Frequency of treatment:
Dosing regime: 7 days/week
No. of animals per sex per dose:
Male: 10 animals at 0 mg/kg bw/day
Male: 5 animals at 40 mg/kg bw/day
Male: 5 animals at 200 mg/kg bw/day
Male: 10 animals at 1000 mg/kg bw/day
Female: 10 animals at 0 mg/kg bw/day
Female: 5 animals at 40 mg/kg bw/day
Female: 5 animals at 200 mg/kg bw/day
Female: 10 animals at 1000 mg/kg bw/day

Results and discussion

Results of examinations

Details on results:
Clinical observations:
For key to symbols, see end of the table.


Dose main groups recovery
groups

(mg/kg 0 40 200 1000 0 1000

bw/d) m f m f m f m f m f m f

1) Clinical examinations

Salivation I I I I

Light- p p p p

colored

feces

2ndwk to

1st wk

posttreatm

ent

Spont. D D

activity,

cutaneous

turgor,

righting

reflex

body D*

weight

gain

Food D* D*

consump-

tion

FOB and motor activity: not tested


urinalysis: no treatment-related effects

Laboratory findings:
For key to symbols, see end of the table.


Dose main groups recovery
groups

(mg/kg 0 40 200 1000 0 1000

bw/d) m f m f m f m f m f m f

2) Clinical laboratory investigations

THRO I* I*

Prothromb I* I* I* I* I*

blood chemistry:

ALAT (GPT) I*

GLUC I*

PROT D* D*

TRIGL I*

Effects in organs:
For key to symbols, see end of the table.


Dose main groups recovery
groups

(mg/kg 0 40 200 1000 0 1000

bw/d) m f m f m f m f m f m f

3) Effect on the organs / Pathology

organ weight: no treatment-related effects

macroscopic findings:

Coating & 5 5

Reddening

of

stomach,

swollen 1 5 5

duodenum

histopathology:

Cardiomyop 2

athy

Duodenum: 3 1 5 3

mucosal

hyperplasi

a


Key: p findings/changes present

i increase compared with controls, no

statistically significant but possibly of

toxicological relevance

i* statistically significant increase compared

with controls (p < 0.05)

d decrease compared with controls, no

statistically significant but possibly of

toxicological relevance

d* statistically significant decrease compared

with controls (p < 0.05)

Effect levels

open allclose all
Dose descriptor:
NOAEL
Effect level:
40 mg/kg bw/day (nominal)
Basis for effect level:
other: original NCD unit is mg/kg/day.
Dose descriptor:
NOEL
Effect level:
40 mg/kg bw/day (nominal)
Basis for effect level:
other: original NCD unit is mg/kg/day.

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion

Conclusions:
Classified as: Not classified